Swiss Re AG (VTX:SREN) has been assigned a consensus recommendation of “Buy” from the twelve ratings firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is CHF 105.31.
SREN has been the subject of several recent research reports. Credit Suisse Group set a CHF 116 price target on Swiss Re and gave the company a “buy” rating in a research note on Thursday, August 8th. HSBC set a CHF 115 target price on Swiss Re and gave the company a “buy” rating in a research report on Monday, June 3rd. Barclays set a CHF 107.70 target price on Swiss Re and gave the company a “buy” rating in a research report on Monday, July 8th. Deutsche Bank set a CHF 108 target price on Swiss Re and gave the company a “neutral” rating in a research report on Wednesday, July 31st. Finally, Goldman Sachs Group set a CHF 110 target price on Swiss Re and gave the company a “buy” rating in a research report on Wednesday, July 31st.
Swiss Re has a one year low of CHF 81.65 and a one year high of CHF 98.80.
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Featured Story: How are Outstanding Shares Different from Authorized Shares?
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.